Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Amy K. Mottl's publication output changed over time?
ScholarIQpublication output · 2004–2026
Output grew0% over the shown period — from 1 works in 2004 to 1 in 2026.
1
1
1
1
2
2
1
1
1
200420142017201820202022202320252026
What are the most-cited papers on Amy K. Mottl?
ScholarIQmost cited works
Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood
Dana Dabelea, Jeanette M. Stafford, Elizabeth J. Mayer-Davis, Ralph B. D’Agostino, Lawrence M. Dolan, Giuseppina Imperatore, Barbara Linder, Jean M. Lawrence, Santica M. Marcovina, Amy K. Mottl, Mary Helen Black, Rodica Pop‐Busui, Sharon Saydah, Richard F. Hamman, Catherine Pihoker
JAMA. 2017696 CitationsOPEN ACCESS
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
Rajiv Agarwal, Jennifer B. Green, Hiddo J.L. Heerspink, Johannes F.E. Mann, Janet B. McGill, Amy K. Mottl, Julio Rosenstock, Peter Rossing, Muthiah Vaduganathan, Meike Brinker, Robert Edfors, Na Li, Markus F. Scheerer, Charlie Scott, Masaomi Nangaku
New England Journal of Medicine. 2025249 CitationsOPEN ACCESS
N-Acetylcysteine for the Prevention of Radiocontrast Induced Nephropathy
Abhijit V. Kshirsagar, Charles Poole, Amy K. Mottl, David A. Shoham, Nora Franceschini, Gail Tudor, Malay Agrawal, Cindy Denu-Ciocca, E. Magnus Ohman, William F. Finn
Journal of the American Society of Nephrology. 2004237 Citations
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy
Jonathan Barratt, Richard Lafayette, Jens Kristensen, Andrew Stone, Daniel Cattran, Jürgen Floege, Vladimı́r Tesař, Hernán Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Brad H. Rovin, Guillermo Fragale, Alejandra Karl, Patricia Losisolo, Hernán Trimarchi, Ivan Gonzalez Hoyos, Mauro Lampo, Matías Monkowski, Jorge de la Fuente, Magdalena Alvarez, Daniela Stoppa, Carlos Chiurchiu, P. Novoa, Marcelo Orías, Maria Belen Barron, Ana Paula Giotto, M. Arriola, Evelin Cassini, Rafaël Maldonado, Maria Paula Dionisi, Jessica Ryan, Nigel D. Toussaint, Grant Luxton, Chen Au Peh, Vicki Levidiotis, Ross S. Francis, Richard Phoon, Elena Fedosiuk, D.M. Toropilov Toropilov, R. E. Yakubtsevich, Elena Mikhailova, Christophe Bovy, Nathalie Demoulin, Jean‐Michel Hougardy, Bart Maes, Marijn M. Speeckaert, Louis‐Philippe Laurin, Sean Barbour, Mélanie Masse, Michelle Hladunewich, Heather N. Reich, Serge Cournoyer, Karthik Tennankore, Sean Barbour, Jicheng Lv, Zhangsuo Liu, Caili Wang, Shaomei Li, Qun Luo, Zhaohui Ni, Tiekun Yan, Ping Fu, Hong Cheng, Bi‐Cheng Liu, Wanhong Lu, Jianqin Wang, Qinkai Chen, D. Wang, Zuying Xiong, Menghua Chen, Yan Xu, Jiali Wei, Pearl Pai, Lianhua Chen, Jitka Řehořová, Dita Maixnerová, Roman Šafránek, Ivan Rychlík, M Hrubý, Satu Mäkelä, Kati Vääräniemi, Fernanda Ortiz, É. Alamartine, Maïté Daroux, C. Cartery, François Vrtovsnik, Jean‐Emmanuel Serre, Eleni Stamellou, Volker Vielhauer, Christian Hugo, Klemens Budde, Britta Otte, Martin Nitschke, Evangelia Ntounousi, Ioannis Boletis, Αikaterini Papagianni, Dimitrios Goumenos, Kostas Stylianou, Synodi Zermpala
Kidney International. 2022218 CitationsOPEN ACCESS
Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes
Vasilios Papademetriou, Laura Lovato, Michael Doumas, Eric Nylén, Amy K. Mottl, Robert M. Cohen, William B. Applegate, Zubin Puntakee, Jean François Yale, William C. Cushman
Kidney International. 2014210 Citations
Related on ScholarIQ
University of North Carolina at Chapel Hill
Institution
Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood
Paper
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
Paper
N-Acetylcysteine for the Prevention of Radiocontrast Induced Nephropathy
Paper
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy
Paper
Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes
Paper